Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Galmed Pharmaceuticals Ltd. (GLMD) had Weighted-Average Shares Outstanding (Diluted) of 4.31M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.31M |
|
-- |
|
-- |
|
$8.51M |
|
$-8.51M |
|
$-1.80M |
|
$-10.31M |
|
$-7.85M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-7.85M |
|
$-8.51M |
|
$-8.49M |
|
4.31M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
4.31M |
$-2.39 |
|
$-2.39 |
|
| Balance Sheet Financials | |
$18.63M |
|
-- |
|
-- |
|
$18.63M |
|
$2.85M |
|
-- |
|
-- |
|
$2.85M |
|
$15.78M |
|
$15.78M |
|
$15.78M |
|
6.58M |
|
| Cash Flow Statement Financials | |
$-6.32M |
|
$-3.38M |
|
$9.03M |
|
$4.77M |
|
$4.11M |
|
$-0.66M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-65.32% |
|
-65.32% |
|
-55.34% |
|
-65.32% |
|
$2.40 |
|
$-1.46 |
|
$-1.46 |
|